Park Ha Biological Technology Co., Ltd.
BYAH· Nasdaq
Who holds Park Ha Biological Technology Co., Ltd., from the managers’ Form 13F reports for the quarter ended Jun 30, 2026.
Form 13F covers managers with $100 million or more. Positions are as of the quarter end and filed up to 45 days later; the latest quarter fills in as reports land.
| Manager | Shares | Change | Value | Of portfolio | Filed |
|---|---|---|---|---|---|
| Morgan Stanley | 25K | +156,250.0% | $25.3K | 0% | Aug 13, 2026 |
| Virtu Financial LLC | 28.4K | New | $29 | 0.1% | Aug 13, 2026 |
| Caitong International Asset Management Co., Ltd | 3 | New | $3 | 0% | Aug 5, 2026 |
| Royal Bank of Canada | 1 | ±0% | $0 | 0% | Aug 14, 2026 |